vs
Esperion Therapeutics, Inc.（ESPR）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是OneStream, Inc.的1.0倍（$168.4M vs $163.7M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 23.6%），过去两年OneStream, Inc.的营收复合增速更高（21.8% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
ESPR vs OS — 直观对比
营收规模更大
ESPR
是对方的1.0倍
$163.7M
营收增速更快
ESPR
高出120.1%
23.6%
两年增速更快
OS
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $163.7M |
| 净利润 | — | $999.0K |
| 毛利率 | — | 69.8% |
| 营业利润率 | 50.6% | -3.2% |
| 净利率 | — | 0.6% |
| 营收同比 | 143.7% | 23.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPROS
| Q4 25 | $168.4M | $163.7M | ||
| Q3 25 | $87.3M | $154.3M | ||
| Q2 25 | $82.4M | $147.6M | ||
| Q1 25 | $65.0M | $136.3M | ||
| Q4 24 | $69.1M | $132.5M | ||
| Q3 24 | $51.6M | $129.1M | ||
| Q2 24 | $73.8M | $117.5M | ||
| Q1 24 | $137.7M | $110.3M |
净利润ESPROS
| Q4 25 | — | $999.0K | ||
| Q3 25 | $-31.3M | $-8.8M | ||
| Q2 25 | $-12.7M | $-18.4M | ||
| Q1 25 | $-40.5M | $-24.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-171.9M | ||
| Q2 24 | $-61.9M | $-7.8M | ||
| Q1 24 | $61.0M | $-5.0M |
毛利率ESPROS
| Q4 25 | — | 69.8% | ||
| Q3 25 | — | 68.1% | ||
| Q2 25 | — | 68.6% | ||
| Q1 25 | — | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% | ||
| Q1 24 | — | 69.1% |
营业利润率ESPROS
| Q4 25 | 50.6% | -3.2% | ||
| Q3 25 | -11.4% | -11.3% | ||
| Q2 25 | 8.6% | -21.8% | ||
| Q1 25 | -34.0% | -29.3% | ||
| Q4 24 | -6.4% | -35.8% | ||
| Q3 24 | -31.0% | -197.6% | ||
| Q2 24 | 3.5% | -9.8% | ||
| Q1 24 | 52.5% | -4.9% |
净利率ESPROS
| Q4 25 | — | 0.6% | ||
| Q3 25 | -35.9% | -5.7% | ||
| Q2 25 | -15.4% | -12.5% | ||
| Q1 25 | -62.2% | -17.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -133.1% | ||
| Q2 24 | -83.9% | -6.7% | ||
| Q1 24 | 44.3% | -4.5% |
每股收益（稀释后）ESPROS
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | $-1.06 | ||
| Q2 24 | $-0.33 | — | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $693.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $504.7M |
| 总资产 | $465.9M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPROS
| Q4 25 | $167.9M | $693.6M | ||
| Q3 25 | $92.4M | $653.9M | ||
| Q2 25 | $86.1M | $652.1M | ||
| Q1 25 | $114.6M | $593.9M | ||
| Q4 24 | $144.8M | $544.2M | ||
| Q3 24 | $144.7M | $495.5M | ||
| Q2 24 | $189.3M | $140.5M | ||
| Q1 24 | $226.6M | — |
股东权益ESPROS
| Q4 25 | $-302.0M | $504.7M | ||
| Q3 25 | $-451.4M | $472.1M | ||
| Q2 25 | $-433.5M | $458.2M | ||
| Q1 25 | $-426.2M | $412.9M | ||
| Q4 24 | $-388.7M | $386.2M | ||
| Q3 24 | $-370.2M | $458.2M | ||
| Q2 24 | $-344.2M | $97.5M | ||
| Q1 24 | $-294.3M | $102.5M |
总资产ESPROS
| Q4 25 | $465.9M | $1.0B | ||
| Q3 25 | $364.0M | $949.4M | ||
| Q2 25 | $347.1M | $910.5M | ||
| Q1 25 | $324.0M | $867.3M | ||
| Q4 24 | $343.8M | $823.2M | ||
| Q3 24 | $314.1M | $750.1M | ||
| Q2 24 | $352.3M | $379.7M | ||
| Q1 24 | $373.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $25.8M |
| 自由现金流经营现金流 - 资本支出 | — | $25.6M |
| 自由现金流率自由现金流/营收 | — | 15.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 25.79× |
| 过去12个月自由现金流最近4个季度 | — | $95.6M |
8季度趋势，按日历期对齐
经营现金流ESPROS
| Q4 25 | $45.2M | $25.8M | ||
| Q3 25 | $-4.3M | $5.0M | ||
| Q2 25 | $-31.4M | $29.7M | ||
| Q1 25 | $-22.6M | $36.2M | ||
| Q4 24 | $-35.0M | — | ||
| Q3 24 | $-35.3M | $2.4M | ||
| Q2 24 | $-7.2M | $8.1M | ||
| Q1 24 | $53.8M | $25.5M |
自由现金流ESPROS
| Q4 25 | — | $25.6M | ||
| Q3 25 | — | $4.8M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | $1.3M | ||
| Q2 24 | $-7.3M | $7.7M | ||
| Q1 24 | $53.8M | $24.9M |
自由现金流率ESPROS
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | 1.0% | ||
| Q2 24 | -9.9% | 6.6% | ||
| Q1 24 | 39.0% | 22.5% |
资本支出强度ESPROS
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ESPROS
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
